In the News
Shire to combine with Baxalta in £22bn deal
12th January 2016
More merger activity in the pharmaceutical sector as Shire and Baxalta confirm their £22billion merger, creating a giant market leader in the treatment of rare diseases.
You might also like
Supersized tankers - is scale going overboard?
21st October 2014
Why do businesses grow?
Study Notes
Conglomerate Integration
Study Notes
Evaluating Mergers and Takeovers
Study Notes
Reducing Contestability using the ‘sardines’ technique
15th May 2014
Business De-mergers
Study Notes
Returns to Scale in Long Run Production
Topic Videos